Excellent
Fully Aligned
Patient Risk:
Low
Summary
The supplied claim is directly supported by the provided FDA label excerpts (Fetal Toxicity 5.1 and Pregnancy 8.1), including the fetal injury/death risk and the instruction to discontinue when pregnancy is detected.
Category Scores
Accurate Statements
Fetal toxicity / injury or death to the developing fetus; discontinue when pregnancy is detected
Supported by Section 5.1 (Fetal Toxicity): 'can cause fetal harm... increased fetal and neonatal morbidity and death' and discontinuation instruction 'When pregnancy is detected, discontinue... as soon as possible.' Also supported by Section 8.1 (Pregnancy): 'can cause fetal harm' and 'When pregnancy is detected, discontinue... as soon as possible.'
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The evaluated claim matches labeled fetal harm risk in pregnancy and the labeled discontinuation guidance when pregnancy is detected.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement